Phase I and pharmacokinetic study of weekly NV06 (Phenoxodiol™), a novel isoflav-3-ene, in patients with advanced cancer

Paul L De Souza^*, Winston Liauw, M. Links, S. Pirabhahar, Graham Kelly, Laurence G Howes

^*Corresponding author for this work

Research output: Contribution to journal › Article › Research › peer-review